Skip to content
healthcare.dev

polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution [Gavilyte-H]

RxNorm concept 1718990, branded drug (sbd). Prescribable name: Gavilyte-H Powder for Oral Solution.

RxCUI
1718990
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/1718990 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Gavilyte-H Powder for Oral Solution; POLYETHYLENE GLYCOL 3350 210000 MG / K+ Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]; POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]

Related concepts

Linked data

NDCs

  • 43386007017

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1718990 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/1718990 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 1718990. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.